Mirnagreen is developing technology for the extraction, production and marketing of bio-active substances of natural origin for the prevention and treatment of human, animals and plants diseases. The company was founded as a spin-off of the Foundation E.Mach and intends to
capitalize on the recent findings obtained by researchers who demonstrate unexpected anti-inflammatory properties of miRNA (microRNA) obtained from plant extracts (patent pending).